1. Home
  2. TISI vs CNTB Comparison

TISI vs CNTB Comparison

Compare TISI & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Team Inc.

TISI

Team Inc.

HOLD

Current Price

$23.95

Market Cap

121.6M

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$0.84

Market Cap

140.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TISI
CNTB
Founded
1973
2012
Country
United States
United States
Employees
6800
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.6M
140.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
TISI
CNTB
Price
$23.95
$0.84
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $5.88
AVG Volume (30 Days)
26.6K
★ 1.5M
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $896,483,000.00
$64,000.00
Revenue This Year
N/A
$11,291.47
Revenue Next Year
N/A
$74.30
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 5.19
N/A
52 Week Low
$12.47
$0.73
52 Week High
$29.57
$3.82

Technical Indicators

Market Signals
Indicator
TISI
CNTB
Relative Strength Index (RSI) 35.52 39.94
Support Level $22.22 N/A
Resistance Level $28.05 $2.62
Average True Range (ATR) 1.27 0.06
MACD -0.22 0.03
Stochastic Oscillator 24.30 57.75

Price Performance

Historical Comparison
TISI
CNTB

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: